The cardiac monitoring and cardiac rhythm management devices market is expected to reach USD 25.12 Billion by 2022 from USD 20.67 Billion in 2017, at a CAGR of 4.0% during the forecast period.
The scope of the report includes cardiac monitoring and cardiac rhythm management devices used for the continuous monitoring, detection, and treatment of heart activities and abnormal heart rhythm (electric heart patterns). The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.
Factors such as the increasing incidence of cardiovascular diseases and technological advancements in devices are expected to propel the growth of the cardiac monitoring market. On the other hand, price sensitivity and limited reimbursements for remote cardiac monitoring devices are expected to limit market growth to a certain extent.
Based on product, the cardiac rhythm management devices market is classified into defibrillators and pacemakers. In 2017, the defibrillators segment accounted for the largest share of the market. The large share of defibrillators can primarily be attributed to the increasing incidence of cardiovascular diseases, development of technologically advanced devices, and increasing demand for these devices in emerging countries.
Based on product, the cardiac monitoring devices market is classified into ECG devices, implantable loop recorders, event monitors, cardiac output monitors, mobile cardiac telemetry, and smart wearable ECG monitors. The mobile cardiac telemetry segment is expected to grow the highest CAGR during the forecast period. Factors such as quick and enhanced diagnosis compared to other short & longer-term monitoring modalities and huge potential for reducing healthcare costs are driving the growth of the market.
Based on end user, the cardiac monitoring and cardiac rhythm management devices market is classified into hospitals, home & ambulatory care settings, and other end users. In 2017, the hospitals segment accounted for the largest share of the market. The large share of this segment can primarily be attributed to the increasing use of these devices in hospitals, growing burden of cardiovascular & coronary heart diseases, increasing number of patient visits to physician offices for the principal diagnosis of CVD & CHD, and growing number of cardiac implant procedures.
Factors such as growing geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies, and less stringent regulations are fueling the demand for CM & CRM devices in the Asia region.
Key Topics Covered:
2 Research Methodology
3 Cardiac Monitoring Market: Executive Summary
4 Cardiac Monitoring Market: Premium Insights 4.1 Cardiac Monitoring and Cardiac Rhythm Management Devices Market Overview 4.2 Asia: Cardiac Monitoring Devices Market, By Product and Country, 2017 vs 2022 (USD Million) 4.3 Defibrillators Market, By Product 4.4 Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User (2017 vs 2022)
5 Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 188.8.131.52 Increasing Incidence of Cardiovascular Diseases 184.108.40.206 Technological Advancements 5.2.2 Restraints 220.127.116.11 Price-Sensitive Market 18.104.22.168 Limited Reimbursements for Remote Cardiac Monitoring Devices 5.2.3 Opportunities 22.214.171.124 Rising Opportunities in Emerging Markets 126.96.36.199 Smart Wearable ECG Monitors 5.2.4 Challenges 188.8.131.52 Dearth of Skilled Professionals With Expertise in Electrocardiography and Cardiac Rhythm Management Devices 184.108.40.206 Frequent Product Recalls
6 CM and CRM Devices Market, By Product 6.1 Introduction 6.2 Cardiac Rhythm Management Devices 6.3 Cardiac Monitoring Devices
7 Cardiac Monitoring Devices Market, By Product 7.1 Introduction 7.2 ECG Devices 7.3 ECG Devices Market, By Type 7.3.1 Resting ECG Systems 7.3.2 Stress ECG Systems 7.3.3 Holter Monitors 7.4 ECG Devices Market, By Lead Type 7.4.1 Single-Lead ECG Leadwires 7.4.2 3-6 ECG Leadwires 7.4.3 12 ECG Leadwires 7.4.4 Other ECG Leadwires 7.5 Implantable Loop Recorders 7.6 Cardiac Output Monitoring (COM) Devices 7.6.1 COM Devices Market, By Type 220.127.116.11 Minimally Invasive COM Devices 18.104.22.168 Noninvasive COM Devices 7.7 Event Monitors 7.7.1 Event Monitors Market, By Type 22.214.171.124 Pre-Symptom (Memory Loop) 126.96.36.199 Post-Symptom Event Monitor 7.7.2 Event Monitors Market, By Technology 188.8.131.52 Autodetect Monitors 184.108.40.206 Manual Event Monitor 7.8 Mobile Cardiac Telemetry Monitoring (MCT/MCOT) 7.9 Smart Wearable ECG Monitors
9 Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User 9.1 Introduction 9.2 Hospitals 9.3 Home and Ambulatory Care Settings 9.4 Other End Users
10 Cardiac Monitoring and Cardiac Rhythm Management Market, By Region
11 Cardiac Monitoring Market: Competitive Landscape 11.1 Introduction 11.2 Competitive Situation and Trends 11.2.1 Product Launches and Approvals 11.2.2 Agreements, Partnerships, and Contracts 11.2.3 Mergers and Acquisitions 11.2.4 Expansions
12 Company Profiles 12.1 Medtronic 12.2 Abbott 12.3 Boston Scientific 12.4 GE Healthcare 12.5 Philips Healthcare 12.6 Biotronik 12.7 Cardiac Science (A Portfolio Company of the Aurora Capital Group) 12.8 Livanova 12.9 Hill-Rom Holdings 12.10 Schiller 12.11 Biotelemetry 12.12 Applied Cardiac System